Brewster David H, Lang Jaroslaw, Bhatti Lesley A, Thomson Catherine S, Oien Karin A
Information Services Division, NHS National Services Scotland, Gyle Square, 1 South Gyle Crescent, Edinburgh EH12 9EB, United Kingdom.
Information Services Division, NHS National Services Scotland, Gyle Square, 1 South Gyle Crescent, Edinburgh EH12 9EB, United Kingdom.
Cancer Epidemiol. 2014 Jun;38(3):227-34. doi: 10.1016/j.canep.2014.03.010. Epub 2014 Apr 13.
Cancers of unknown primary site (CUP) pose problems for diagnosis, treatment, and accurate prediction of prognosis. However, there are limited published data describing the epidemiology of this disease entity. Our aim was to describe the epidemiology of CUP in Scotland.
Anonymised data, covering the period 1961-2010, were extracted from the Scottish Cancer Registry database, based on the following ICD-10 diagnostic codes: C26.0, C26.8, C26.9, C39, and C76-C80. Age-standardised incidence rates were calculated by direct standardisation to the World Standard Population. Estimates of observed survival were calculated by the Kaplan-Meier method.
Between 1961 and 2010, there were 50,941 registrations of CUP, representing 3.9% of all registrations of invasive cancers. Age-standardised rates increased to a peak in the early to mid-1990s, followed by a steeper decrease in rates. During 2001-2010, age-standardised rates of CUP were higher in the most compared with the least deprived fifth of the population. Observed survival was marginally higher in patients diagnosed during 2001-2010 (median 5.6 weeks) compared with those diagnosed in the previous two decades. During the most recent decade, survival decreased with age at diagnosis, and was higher in patients with squamous cell carcinoma and with lymph node metastases.
Patterns of CUP in Scotland are largely consistent with those reported from the few other countries that have published data. However, in comparing studies, it is important to note that there is heterogeneity in terms of definition of CUP, as well as calendar period of diagnosis or death. Variation in the definition of CUP between different epidemiological studies suggests that there would be merit in seeking international agreement on guidelines for the registration of CUP as well as a standard grouping of diagnostic codes for analysis.
原发部位不明的癌症(CUP)在诊断、治疗及准确预后预测方面存在诸多问题。然而,关于这一疾病实体流行病学的已发表数据有限。我们的目的是描述苏格兰CUP的流行病学情况。
基于以下ICD - 10诊断编码:C26.0、C26.8、C26.9、C39以及C76 - C80,从苏格兰癌症登记数据库中提取了1961年至2010年期间的匿名数据。通过直接标准化到世界标准人口计算年龄标准化发病率。采用Kaplan - Meier方法计算观察到的生存率。
1961年至2010年期间,有50941例CUP登记病例,占所有侵袭性癌症登记病例的3.9%。年龄标准化发病率在20世纪90年代初至中期达到峰值,随后下降幅度更大。在2001 - 2010年期间,CUP的年龄标准化发病率在最贫困的五分之一人群中高于最不贫困的五分之一人群。2001 - 2010年期间诊断的患者观察到的生存率(中位生存期5.6周)略高于前二十年诊断的患者。在最近十年中,生存率随诊断时年龄的增加而降低,鳞状细胞癌患者和有淋巴结转移的患者生存率较高。
苏格兰CUP的模式在很大程度上与其他少数已发表数据的国家所报告的模式一致。然而,在比较研究时,重要的是要注意到CUP的定义、诊断或死亡的日历期存在异质性。不同流行病学研究中CUP定义的差异表明,寻求关于CUP登记指南以及用于分析的诊断编码标准分组的国际共识是有价值的。